http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105671187-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2016-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105671187-B |
| titleOfInvention | Group of genes for molecular typing of head and neck squamous cell carcinoma and application thereof |
| abstract | The invention provides a group of genes for HNSCC molecular typing, which comprise a TP53 gene, a CDKN2A gene, a FAT1 gene, a CASP8 gene, an AJUBA gene, a PIK3CA gene, a NOTCH1 gene, a KMT2D gene, an NSD1 gene, an HLA-A gene, an HRAS gene, an FBXW7 gene, an RB1 gene, a PIK3R1 gene, a TRAF3 gene, an NFE2L2 gene, a CUL3 gene and a PTEN gene. The invention also provides application of the gene in preparation of a kit and a gene chip for HNSCC molecular typing, and the kit and the gene chip for HNSCC molecular typing prepared by using the gene. The method can enhance the rationality and accuracy of HNSCC typing, thereby providing key technical support for realizing early diagnosis, effective blocking and individualized treatment of HNSCC. |
| priorityDate | 2016-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 140.